Recruitment Milestone Reached in Diamyd^® Phase III Trial

Diamyd Medical’s precision medicine Phase III trial for Type 1 Diabetes, DIAGNODE-3, has enrolled 100 patients. To date, no serious adverse events have been reported, and no patients have discontinued the trial.